Who we are
Cross Border Impact Ventures aims to be the preferred investor for transformative health technology companies with the potential of meeting the needs of women, children and adolescents across global markets
Current AUM
50M-100M

Sectors
Femtech, Healthcare
Stages
Seed, Series A, Series B
Regions
Europe, North America
Countries
France, UK, US
Founding / General Partners
Annie Theriault, Donna Parr